Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00334763 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped Principal Investigator felt risk to patients was too high.

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: carboplatin
DRUG: chemoprotection
DRUG: paclitaxel
RADIATION: radiation therapy

Sponsor

Northwestern University

Collaborators

[object Object]